Treffer: Use of cerebral embolic protection devices for endovascular treatment of a stenotic brachiocephalic trunk.

Title:
Use of cerebral embolic protection devices for endovascular treatment of a stenotic brachiocephalic trunk.
Authors:
Irvine V; Vascular Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia vanessa.irvine@health.nsw.gov.au., Archer JP; Vascular Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia.; Wagga Wagga Base Hospital, Wagga Wagga, New South Wales, Australia., Crozier J; Vascular Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia.
Source:
BMJ case reports [BMJ Case Rep] 2025 Jul 16; Vol. 18 (7). Date of Electronic Publication: 2025 Jul 16.
Publication Type:
Journal Article; Case Reports
Language:
English
Journal Info:
Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE
Imprint Name(s):
Original Publication: London : BMJ Pub. Group
Contributed Indexing:
Keywords: Arteries; Stroke; Surgery; Vascular surgery
Entry Date(s):
Date Created: 20250716 Date Completed: 20250716 Latest Revision: 20250716
Update Code:
20250717
DOI:
10.1136/bcr-2025-265592
PMID:
40669884
Database:
MEDLINE

Weitere Informationen

High-grade brachiocephalic artery stenosis is a rare manifestation of atherosclerotic disease with significant implications for patient morbidity, mortality and stroke risk. Clinical presentation often includes ischaemic symptoms affecting the right upper limb or cerebral circulation. Endovascular intervention has emerged as the preferred management strategy, demonstrating reduced overall risk and complication rates; however, challenges remain, particularly regarding intraoperative stroke risk. This study presents a case of symptomatic brachiocephalic artery stenosis in an elderly woman managed with endovascular stenting using dual neuroprotective filters. This novel technique, not previously documented, demonstrates feasibility in similar clinical scenarios. The patient experienced a successful outcome with complete symptom resolution and remained complication-free at a 6-week follow-up.
(© BMJ Publishing Group Limited 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.)

Competing interests: None declared.